Ramsay Health Care
Australia's largest private hospital operator, also running hospitals in the UK and France.
On the record
Checkpoint: Ramsay Sante shareholder vote on demerger, with completion targeted the following month
The call
Ramsay is splitting off its French business, fixing a troubled UK mental health unit, and absorbing hospitals from a failed Australian rival, all at once.
Ramsay Health Care runs private hospitals across Australia and the UK, earning money by treating patients and billing insurance companies and governments. It is hard to copy because it owns most of its hospital buildings, has long-term contracts with insurers locked in until 2043, and holds government partnership agreements. The main Australian rival, Healthscope, collapsed in 2025, so Ramsay is picking up that business. The one thing that could change everything is whether Ramsay can keep its profits healthy when nurses and doctors keep demanding higher pay but insurance companies and governments are not raising what they pay Ramsay for patient care.
Why
01
AI pressure: None apparent. No AI product replaces surgical theatres, hospital beds, or insurer contracts; digital tools support care, they don't take patients. Could AI do the core job? Unlikely.
02
Bigger players: None apparent. NHS and Medicare-funded public systems send overflow patients to Ramsay rather than competing it away; Healthscope, its main rival, entered administration in 2025. Could a giant copy it? No, they are blocked.
03
What protects it. Owned hospital real estate, licensing, and multi-year insurer and public-partnership contracts running to 2043 keep patient flow locked in.
What would change this call
Ramsay Santé shareholder vote on demerger, November 2026. Shows whether the standalone-split plan proceeds or stalls.
Elysium UK financial results under new CEO through 2026. Indicates whether the UK turnaround stabilizes or triggers further impairments.
FY26 full-year results, due around August 2026. Reveals whether wage costs and insurer reimbursement gaps widen or narrow margins.
Elysium UK financial results under new CEO through 2026. Indicates whether the UK turnaround stabilizes or triggers further impairments.
FY26 full-year results, due around August 2026. Reveals whether wage costs and insurer reimbursement gaps widen or narrow margins.
Key numbers
- FY25 group revenue A$17.85 billion, up 6.8% YoY
- Elysium UK impairment: A$291 million post-tax
- ACCC cleared Ramsay's Healthscope hospital buy
Named risks
- Wage inflation outpacing insurer reimbursement growth compresses hospital margins.
- Further Elysium UK impairment after Jan 2026 CEO turnaround attempt.
- Ramsay Sante demerger vote (Nov 2026) or completion (Dec 2026) could fumble or delay.
- Activist investor Perpetual pressing for governance and capital-discipline changes since 2022 de-rating.
- Healthscope asset auctions could shift some acquired hospitals to rivals like Calvary instead of Ramsay.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| Healthscope | gaining on | Healthscope entered administration May 2025; Ramsay acquired its National Capital Private Hospital, cleared Feb 2026 |
| Calvary Health Care | contesting | Contesting Healthscope's Hobart Private Hospital acquisition, industry submission filed June 2026 |
| Spire Healthcare | losing to | Ramsay UK's ~£1bn 2021 takeover bid for Spire was rejected |
| ELSAN (KKR-owned) | contesting | Major French private hospital rival; KKR's Elsan ownership cited in its 2022 Ramsay bid |
Questions people ask
- Is Ramsay Health Care in financial trouble?
- No signs of distress appear in the numbers: trailing twelve-month revenue was A$18.62 billion, up 8.95% year-on-year as of 31 Dec 2025, and market capitalization sat around A$9.77 billion on 25 Jul 2026. The real pressure is margin-related, not solvency-related, since insurer payment indexation has been lagging wage and labor cost growth, a trend to check when FY26 full-year results land around August 2026.
- Who are Ramsay Health Care's biggest competitors?
- Named rivals include Spire, Nuffield Health, and HCA UK in Britain, plus ELSAN in France, whose KKR-backed roughly A$20 billion takeover bid for Ramsay collapsed in September 2022. Notably, Ramsay's main Australian competitor Healthscope collapsed into receivership in May 2025 carrying A$1.6 billion in debt, and Ramsay bought Healthscope's Canberra hospital for A$251m in February 2026, a sign it is gaining ground rather than losing patients to competitors.
- Is Ramsay Health Care at risk from AI?
- Current AI tools touch scheduling and documentation, not ICU beds, operating theatres, or insurer contracts, so this is treated as not applicable to Ramsay's core business. Little of Ramsay's core hospital operation is exposed to software substitution, given the physical, regulated nature of running private hospitals.
- What is the biggest risk facing Ramsay Health Care?
- The main pressure is a cost and reimbursement squeeze rather than patients switching providers. Insurer payment indexation lagging wage and labor cost growth is the specific mechanism to watch, with FY26 full-year results due around August 2026 expected to show whether that margin pressure has eased or continued.
- Could a large competitor or private equity buyer take over Ramsay's market position?
- No big company is currently challenging Ramsay's hospital licenses or insurer contracts. New private hospital licenses are hard to obtain due to regulatory and capital barriers, and Ramsay's scale across Australia, the UK, France, and the Nordics lets it absorb distressed rivals' assets, as shown by its A$251m purchase of Healthscope's Canberra hospital in February 2026, rather than lose ground to an outside buyer.
- What should I watch to see if Ramsay Health Care stays on track?
- Two dated checkpoints matter: the Ramsay Sante demerger requires a 75% shareholder approval vote expected by December 2026, and FY26 full-year results due around August 2026 will show whether insurer indexation continues to lag labor cost growth. Both are verifiable events rather than predictions, and they carry real weight for the company's near-term trajectory.
Timeline
- 2026-07-21Ramsay UK sold mobile diagnostic imaging fleet to Medneo under six-year contract
- 2026-07-01Paul Ramsay Foundation stake filed at ~16.4%, down from ~18.8% in 2022
- 2026-02-12ACCC cleared Ramsay's acquisition of National Capital Private Hospital
- 2026-02-01Ramsay proposed Ramsay Sante demerger; vote Nov 2026, completion targeted Dec 2026
- 2026-01-12Joe O'Connor appointed new CEO of Elysium UK to drive turnaround
- 2025-12-01Ramsay acquired National Capital Private Hospital from Healthscope
- 2025-08-28Joondalup Health Campus public-private partnership extended to 2043
- 2025-05-01Rival Healthscope entered voluntary administration
- 2025-02-10A$291m post-tax Elysium UK impairment; Ramsay scrapped FY25 profit growth target
- 2022-09-26KKR-led ~A$20bn buyout of Ramsay collapsed after due-diligence dispute
Revision history
30 July 2026
First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- FY25 financial results
- Ramsay Health Care analysis (2025-08-27)
- RHC revenue data (2026-06-28)
- Ramsay Health competitive analysis (2026-03-19)
- Ramsay Health Care Ltd Company Profile
- ACCC Phase 1 determination on Ramsay / National Capital Private Hospital (2026-02-12)
- RHC employee count (2026-07-14)
- IBISWorld Ramsay Health Care Limited profile
- Revelio Labs Ramsay Health Care employees (2026-07-01)
- Ramsay Santé press release (2026-07-23)
- Capital Brief: Ramsay Health Care (2025-02-10)
- RNS filing